In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Diagnostic services | 12.7 | 9.9 | | | | | | |
Royalties | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | | |
Services | | | | | | | 3.3 | 2.3 |
Products | | | | | | | 0.3 | 0.2 |
Other | | | 7.9 | 6.2 | 5.2 | 4.6 | | |
Total revenues [+] | 12.9 | 10.1 | 8.0 | 6.4 | 5.4 | 4.7 | 3.6 | 2.6 |
Royalties | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | | |
Products | | | | | | | 0.3 | |
Services | 12.7 | 9.9 | | | | | 3.3 | |
Net interest income | -0.1 | -0.1 | | | | | | |
Revenue growth [+] | 27.6% | 25.4% | 26.3% | 19.0% | 14.9% | 31.1% | 38.1% | -58.9% |
Diagnostic services | 27.7% | | | | | | | |
Royalties | 17.7% | -1.3% | -8.6% | -9.4% | 80.0% | | | |
Services | | | | | | | 40.6% | 37.8% |
Products | | | | | | | 13.9% | -85.2% |
Cost of goods sold [+] | 5.8 | 5.4 | 4.4 | 3.5 | 2.7 | 2.6 | 2.2 | 1.5 |
Cost of product sales | | | | | | | 0.3 | |
Cost of services | | | | | | | 1.9 | |
Gross profit | 7.1 | 4.6 | 3.6 | 2.8 | 2.6 | 2.0 | 1.4 | 1.1 |
Gross margin | 55.0% | 46.0% | 44.9% | 44.6% | 49.5% | 43.3% | 38.5% | 41.8% |
Selling, general and administrative [+] | 10.6 | 10.5 | 11.5 | 8.0 | 8.0 | 8.3 | 7.7 | 6.5 |
Sales and marketing | 4.6 | 5.0 | 4.3 | 2.8 | 2.6 | 2.7 | 1.9 | |
General and administrative | 6.0 | 5.5 | 7.2 | 5.2 | 5.4 | 5.6 | 5.8 | |
Research and development | 0.5 | 0.5 | 0.7 | 1.0 | 1.4 | 1.4 | 2.0 | 2.8 |
Equity in earnings | | | | | | | | 0.6 |
Other operating expenses | 0.1 | 0.2 | 0.1 | 0.3 | 0.3 | 0.3 | -19.2 | 0.9 |
EBITDA [+] | -3.8 | -6.2 | -8.4 | -5.7 | -6.5 | -7.6 | 11.4 | -7.0 |
EBITDA growth | -38.6% | -26.0% | 48.1% | -12.4% | -14.2% | -166.3% | -263.0% | -41.2% |
EBITDA margin | -29.8% | -61.9% | -104.9% | -89.5% | -121.5% | -162.8% | 322.0% | -272.9% |
Depreciation and amortization | 0.2 | 0.2 | 0.2 | 0.4 | 0.2 | 0.1 | 0.4 | 1.5 |
EBITA | -4.0 | -6.4 | -8.6 | -6.1 | -6.7 | -7.6 | 11.1 | -8.5 |
EBITA margin | -31.0% | -63.8% | -107.4% | -96.5% | -125.7% | -163.8% | 311.1% | -331.3% |
Amortization of intangibles | 0.1 | 0.1 | 0.1 | 0.3 | 0.3 | 0.3 | 0.2 | |
EBIT [+] | -4.1 | -6.5 | -8.8 | -6.4 | -7.0 | -7.9 | 10.9 | -8.5 |
EBIT growth | -37.4% | -25.3% | 36.9% | -8.5% | -11.5% | -172.7% | -227.4% | -37.5% |
EBIT margin | -31.8% | -64.8% | -108.9% | -100.4% | -130.7% | -169.6% | 305.7% | -331.3% |
Non-recurring items [+] | | | | | | | 36.3 | |
Asset impairment | | | | | | | 16.9 | |
Legal settlement | | | | | | | 19.4 | |
Interest expense, net [+] | 0.0 | 0.1 | 0.1 | 0.4 | 0.2 | 0.0 | 0.4 | 2.1 |
Interest expense | 0.1 | 0.1 | 0.1 | 0.4 | 0.2 | 0.0 | 0.4 | 2.1 |
Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Other income (expense), net [+] | | | 0.1 | 2.8 | -2.4 | | 19.9 | -0.8 |
Impairment of investments | | 0.1 | | | | | | |
Gain (loss) on debt retirement | | | | | | | -0.6 | |
Gain (loss) on derivative instruments | | | 0.2 | 2.8 | | | 0.6 | |
Other non-operating income | | | | | | | 0.5 | |
Other | 0.0 | -0.1 | 0.0 | 2.5 | -2.5 | 0.0 | -0.5 | |
Pre-tax income | -4.1 | -6.6 | -8.7 | -3.9 | -9.5 | -7.9 | -5.9 | -11.4 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | 7.2 | 6.2 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 4.0% | | |
Net income | -5.8 | -7.7 | -8.7 | -12.2 | -10.3 | -7.6 | -13.1 | -17.6 |
Net margin | -44.9% | -75.9% | -108.3% | -191.8% | -191.9% | -163.1% | -369.0% | -685.5% |
|
Basic EPS [+] | ($3.27) | ($9.22) | ($11.84) | ($3.10) | ($9.43) | $988,166.45 | ($0.77) | ($1.60) |
Growth | -64.5% | -22.2% | 282.1% | -67.1% | -100.0% | -127823283.9% | -51.6% | -35.0% |
Diluted EPS [+] | ($3.27) | ($9.22) | ($11.84) | ($3.10) | ($9.43) | $988,166.45 | ($0.77) | ($1.60) |
Growth | -64.5% | -22.2% | 282.1% | -67.1% | -100.0% | -127823283.9% | -51.6% | -35.0% |
|
Shares outstanding (basic) [+] | 1.8 | 0.8 | 0.7 | 3.9 | 1.1 | 0.0 | 7.6 | 7.1 |
Growth | 112.8% | 13.0% | -81.3% | 261.9% | -14159176.7% | -100.0% | 6.7% | 16.9% |
Shares outstanding (diluted) [+] | 1.8 | 0.8 | 0.7 | 3.9 | 1.1 | 0.0 | 7.6 | 7.1 |
Growth | 112.8% | 13.0% | -81.3% | 261.9% | -14159176.7% | -100.0% | 6.7% | 16.9% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |